Matthew Metz

1.3k total citations · 1 hit paper
15 papers, 960 citations indexed

About

Matthew Metz is a scholar working on Molecular Biology, Plant Science and Infectious Diseases. According to data from OpenAlex, Matthew Metz has authored 15 papers receiving a total of 960 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Plant Science and 2 papers in Infectious Diseases. Recurrent topics in Matthew Metz's work include CRISPR and Genetic Engineering (5 papers), Genetically Modified Organisms Research (5 papers) and Insect Resistance and Genetics (3 papers). Matthew Metz is often cited by papers focused on CRISPR and Genetic Engineering (5 papers), Genetically Modified Organisms Research (5 papers) and Insect Resistance and Genetics (3 papers). Matthew Metz collaborates with scholars based in United States, Switzerland and United Kingdom. Matthew Metz's co-authors include Brian J. Staskawicz, Michael J. Daniels, Jane E. Parker, Eric B. Holub, Anne M. Thomson, Johannes Fütterer, Linda S. Thomashow, Milton P. Gordon, Bassem Al‐Sady and Douglas Dahlbeck and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Biotechnology.

In The Last Decade

Matthew Metz

14 papers receiving 911 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Different requirements for EDS1 and NDR1 by disease resistance genes define at least two R gene-mediated signaling pathways in Arabidopsis

1998 626 citations Matthew Metz, Eric B. Holub et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Matthew Metz

Since Specialization

Citations

This map shows the geographic impact of Matthew Metz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Metz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Metz more than expected).

Fields of papers citing papers by Matthew Metz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Metz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Metz. The network helps show where Matthew Metz may publish in the future.

Co-authorship network of co-authors of Matthew Metz

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Metz. A scholar is included among the top collaborators of Matthew Metz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Metz. Matthew Metz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Bacillus thuringiensis 2024 ·Matthew Metz	0
2	Eight More Ways To Deal with Antibiotic Resistance 2014 ·Antimicrobial Agents and Chemotherapy ·Matthew Metz, David M. Shlaes	20
3	State-of-the-Art Therapeutic Medical Countermeasures for Viral Threat Agents 2011 ·Biosecurity and Bioterrorism Biodefense Strategy Practice and Science ·Aruna Sampath, Matthew Metz, (unknown), Joseph C. Larsen	2
4	State‐of‐the‐art therapeutic medical countermeasures for bacterial threat agents 2011 ·Drug Development Research ·(unknown), Matthew Metz, Aruna Sampath, Joseph C. Larsen	4
5	The conserved Xanthomonas campestris pv. vesicatoria effector protein XopX is a virulence factor and suppresses host defense in Nicotiana benthamiana 2005 ·The Plant Journal ·Matthew Metz, Douglas Dahlbeck, (unknown), Bassem Al‐Sady, (unknown), Brian J. Staskawicz	70
6	Research Opportunities in Food and Agriculture Microbiology 2005 ·Michael P. Doyle, Lee‐Ann Jaykus, Matthew Metz	4
7	Bacillus thuringiensis: A Cornerstone of Modern Agriculture 2003 ·Matthew Metz	11
8	Purine synthesis and increasedAgrobacterium tumefacienstransformation of yeast and plants 2003 ·Proceedings of the National Academy of Sciences ·(unknown), Matthew Metz, Dave E. Monks, (unknown), Tyler Hall, Eugene W. Nester	29
9	Suspect evidence of transgenic contamination (see editorial footnote) 2002 ·Nature ·Matthew Metz, Johannes Fütterer	47
10	Criticism preserves the vitality of science 2002 ·Nature Biotechnology ·Matthew Metz	1
11	100 Years of Bacillus thuringiensis: A Critical Scientific Assessment 2002 ·(unknown), Linda S. Thomashow, Matthew Metz, Milton P. Gordon	62
12	Conflicts around a study of Mexican crops 2002 ·Nature ·Matthew Metz, Johannes Fütterer	2
13	What Good Is Agricultural Biotechnology? 2000 ·Journal of New Seeds ·Matthew Metz	3
14	Different requirements for EDS1 and NDR1 by disease resistance genes define at least two R gene-mediated signaling pathways in Arabidopsis breakdown → 1998 ·Proceedings of the National Academy of Sciences ·(unknown), Matthew Metz, Eric B. Holub, Brian J. Staskawicz, Michael J. Daniels, Jane E. Parker	626
15	Implications of economic policy for food security: A training manual 1997 ·University of Florida Digital Collections (University of Florida) ·Anne M. Thomson, Matthew Metz	79

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact